In this commentary, Raymond Chung, MD, from Massachusetts General Hospital, explains why it is key to stage a patient’s disease after an HCV diagnosis—and how to do it.
Commentary: Even Modest Reductions in Blood Pressure Can Lead to Substantial Reductions in Cardiovascular Events
In this article, Michael J. Bloch, MD, writes about studies over the past 30 years that prove lower achieved blood pressure, including modest reductions in blood pressure, translates to lower cardiovascular events.
In this commentary, Diane Vizthum, a nutritionist from Johns Hopkins, outlines the research done on the ketogenic diet, whether it benefits heart health, and which patients may actually benefit from the diet.
Ophthalmologist Sonal Tuli, MD, discusses the FDA’s recent approval of teprotumumab for thyroid eye disease and what this new drug adds to the treatment landscape for this condition.
Use of Probiotics in Pediatric Patients: A Review of the American Gastroenterological Association 2020 Guidelines
In August 2020, the American Gastroenterological Association published clinical practice guidelines for the role of probiotics in the management of gastrointestinal disorders. The document is not specific to pediatric practice per se, but recommendations are included for specific populations that include children and neonates.
In this commentary, Charlotte Owens, MD, reviews data from the American College of Obstetricians and Gynecologists Annual Clinical and Scientific Meeting, including study findings on treatment options for endometriosis and uterine fibroids.
In this Editorial, Editorial Board Member Michael J. Bloch, MD, reflects on a 1985 article from Consultant’s archives about how to properly use the laboratory to monitor drug therapy among patients with hypertension.
In this commentary, Michael Bloch, MD, writes about the cardiovascular manifestations of Fabry disease in men and women, the diagnosis of patients presenting with unexplained cardiovascular disease, and available treatments for patients with Fabry disease.
In this article, Scott T. Vergano, MD, writes about follow-up care for cancer survivors, diagnosis of hematogenous osteomyelitis, and type 1 and type 2 diabetes in pediatric patients. He also writes about the differences in earning potential for pediatric and adult physicians.
In this commentary, Michael Bloch, MD, writes about renin-angiotensin system-blocking agents and how they affect the disease course of COVID-19.